Fibrogen Inc. sell Bank of America Co.
Start price
08.08.23
/
50%
€1.55
Target price
08.08.24
€1.83
Performance (%)
-30.23%
Price
10.05.24
€1.08
Summary
This prediction is currently active. The SELL prediction by Bank_of_America_Co_ for Fibrogen Inc. is performing very well with a performance of -30.23%. This prediction currently runs until 08.08.24. The prediction end date can be changed by Bank_of_America_Co_ at any time. Bank_of_America_Co_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Fibrogen Inc. | 2.560% | 2.560% |
iShares Core DAX® | 4.094% | 3.543% |
iShares Nasdaq 100 | 1.424% | 0.512% |
iShares Nikkei 225® | -1.572% | -4.633% |
iShares S&P 500 | 1.822% | 0.963% |
Comments by Bank_of_America_Co_ for this prediction
In the thread Fibrogen Inc. diskutieren
FibroGen, Inc. (NASDAQ: FGEN) was downgraded by analysts at Bank of America Co. from a "neutral" rating to an "underperform" rating. They now have a $2.00 price target on the stock, down previously from $4.00.
Ratings data for FGEN provided by MarketBeat